Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 141,209 | 110,463 | 63,250 | 27,762 | 106,140 |
| Depreciation Amortization | -9,602 | 876 | 377 | 179 | -6,766 |
| Income taxes - deferred | -40,191 | -36,333 | -21,126 | -7,162 | -29,493 |
| Accounts receivable | -12,853 | -18,594 | -12,714 | -20,395 | -10,066 |
| Accounts payable and accrued liabilities | -2,020 | 1,086 | 1,735 | -4,861 | 5,420 |
| Other Working Capital | 45,525 | 27,420 | -132 | -7,413 | 7,860 |
| Other Operating Activity | 76,227 | 53,319 | 33,554 | 35,646 | 53,586 |
| Operating Cash Flow | $198,295 | $138,237 | $64,944 | $23,756 | $126,681 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -588,310 | -111,193 | -68,792 | -9,014 | -328,748 |
| PPE Investments | -2,172 | -2,051 | -416 | N/A | -139 |
| Purchase Of Investment | 412,878 | N/A | N/A | N/A | 419,793 |
| Investing Cash Flow | $-177,604 | $-113,244 | $-69,208 | $-9,014 | $90,906 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,616 | 7,195 | 4,926 | 749 | 5,811 |
| Common Stock Repurchased | -15,664 | -15,664 | -3,954 | 464 | -145,428 |
| Other Financing Activity | -22,301 | -15,316 | -3,665 | -1,756 | -9,106 |
| Financing Cash Flow | $-28,349 | $-23,785 | $-2,693 | $-543 | $-148,723 |
| Exchange Rate Effect | -228 | 530 | -6 | N/A | 358 |
| Beginning Cash Position | 135,551 | 135,551 | 135,551 | 135,551 | 66,329 |
| End Cash Position | 127,665 | 137,289 | 128,588 | 149,750 | 135,551 |
| Net Cash Flow | $-7,886 | $1,738 | $-6,963 | $14,199 | $69,222 |
| Free Cash Flow | |||||
| Operating Cash Flow | 198,295 | 138,237 | 64,944 | 23,756 | 126,681 |
| Capital Expenditure | -2,172 | -2,051 | -416 | 0 | -139 |
| Free Cash Flow | 196,123 | 136,186 | 64,528 | 23,756 | 126,542 |